-8.7%
KVUE vs GSK
+47.2%
-55.9%
-41.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.1% | 0.0% | -0.1% | -0.1% |
| 7D | -5.1% | -3.5% | -1.6% | -4.5% |
| 30D | -6.3% | -3.4% | -2.9% | -5.7% |
| 3M | -0.5% | -8.1% | +7.6% | +1.0% |
| 6M | +3.1% | -11.1% | +14.2% | +5.2% |
| YTD | +6.7% | +0.7% | +5.9% | +6.4% |
| 1Y | -1.1% | +20.1% | -21.3% | -5.0% |
| 3Y | -8.7% | +46.1% | -54.9% | -17.2% |
| All | -8.7% | +47.2% | -55.9% | -17.2% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling